European Archives - Page 12 of 1078 - European Medical Journal

Systemic Sclerosis Increases Risk of Lung, Gynaecological, and Blood Cancers

Patients with systemic sclerosis (SSc) face a higher risk of death from lung, gynecological cancers, and T/NK lineage lymphomas, according to a new study.

Glucose-Lowering Medications Reduce COPD Exacerbation Risk

New research finds that SGLT-2is and GLP-1RAs are associated with a lower risk of COPD exacerbations in patients with Type 2 diabetes and active COPD.

EAU 2025 - WATER III Trial: Waterjet vs Laser for Large Prostates in Benign Prostatic Hyperplasia

Waterjet surgery preserves ejaculation in 85% of patients with benign prostatic hyperplasia . Laser alternatives lag at 23%.

Breakthrough CRISPR Test Detects Pathogens in Minutes

The new CRISPR-Cascade assay eliminates the need for nucleic acid amplification, enabling highly sensitive detection of pathogens within minutes.

Children Face Higher Risk of Long-Term Gastrointestinal Issues After COVID-19

A new study found that children with COVID-19 have a 25% higher risk of developing persistent gastrointestinal symptoms months after infection.

New Endometriosis Pill New Hope for Patients

With the approval of Ryeqo, endometriosis patients in the UK will benefit from a treatment that enhances convenience and autonomy.

Heated Lidocaine Gel Could Reduce Pain in Transrectal Ultrasound-Guided Prostate Biopsy

A new study suggests heated lidocaine gel combined with periprostatic nerve block reduces pain during prostate biopsy without increasing complications.

Red Versus White Wine: A Difference in Cancer Risk?

A new meta-analysis challenges the widely held belief that red wine is a healthier alternative to other alcoholic beverages.

Yttrium-90 Transarterial Radioembolisation may Prolong Survival with Hepatocellular Carcinoma

Yttrium-90 radioembolisation may offer improved survival for large hepatocellular carcinoma tumours compared to transarterial hepatic embolisation.

Vitamin D Significantly Reduces MS Disease Activity, Landmark Trial Shows

High-dose vitamin D delays MS progression by 200 days in early-stage patients. MRI data shows significant benefits.